News

Gilead's bi-annual HIV prevention jab gets FDA approval: How much does it cost and how it works? All you need to know…
Gilead Sciences has received US FDA approval for Yeztugo, its bi-annual HIV prevention injection, which has shown 96 per cent ...
sharewise1h
FDA Approves Gilead's Twice-Yearly Shot for HIV Prevention
Gilead Sciences, Inc. GILD obtained FDA approval for its twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, for the ...
PharmExec3h
FDA Approves Gilead’s Yeztugo as First Twice-Yearly Injection for HIV Pre-Exposure Prophylaxis
Approval of first twice-yearly HIV pre-exposure prophylaxis was based on results from the Phase III PURPOSE 1 and PURPOSE 2 ...
Pharmaceutical Technology on MSN12h
Gilead Sciences’ Yeztugo receives approval from US FDA for HIV
This is a historic day in the decades-long fight against HIV. Yeztugo is one of the most important scientific breakthrou ...
STAT13h
Gilead’s CEO on the approval of a powerful new drug to prevent HIV
Gilead's CEO says he's committed to making sure people around the world can get his firm's new HIV prevention shot Yeztugo.
Scientists develop new drug for virus affecting lakhs each year, offers 99.9% protection with two injections, it is priced at Rs...
More than a million people are infected every year with the Human Immunodeficiency Virus (HIV), despite decades of work ...
PMLive10h
Gilead Sciences’ twice-yearly HIV PrEP drug Yeztugo granted FDA approval
Gilead Sciences’ twice-yearly injectable pre-exposure prophylaxis (PrEP) drug has been approved by the US Food and Drug ...
FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
The Pharma Letter9h
Gilead’s PrEP Yeztugo gains FDA green light
The US Food and Drug Administration (FDA) has approved Gilead Sciences (Nasdaq: GILD) Yeztugo (lenacapavir) - the company’s ...
Mother Jones1h
FDA Approves “Breakthrough” HIV Drug
On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...
FDA approves first twice-yearly injection that prevents HIV infection
The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly alternative to daily medications.
BioPharma Dive1d
FDA approves twice-yearly shot of Gilead drug for HIV prevention
The clearance ushers in a closely-watched launch for Gilead, which aims to show a long-acting injection can upend a market ...